Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REPAGLINIDE vs RESMETIROM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REPAGLINIDE vs RESMETIROM: Safety Overview

Metric REPAGLINIDE RESMETIROM
Total FAERS Reports 2,544 881
Deaths Reported 169 26
Death Rate 6.6% 3.0%
Hospitalizations 1,517 50
Average Patient Age 71.9 yrs 58.1 yrs
% Female Patients 45.5% 65.3%
FDA Approval Date Apr 24, 2015 Mar 14, 2024
Manufacturer Rising Pharma Holdings, Inc. Madrigal Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription